Long-term tracking of Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy use
Multi-Institution Registry of SRS/SBRT Procedures
This study is tracking how well Stereotactic Radiosurgery and Stereotactic Body Radiation Therapy work for treating tumors over time to help improve patient care.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 50000 (estimated) |
| Sex | All |
| Sponsor | The Radiosurgery Society Academic / other |
| Drugs / interventions | Radiation |
| Locations | 13 sites (Colorado Springs, Colorado and 12 other locations) |
| Trial ID | NCT01885299 on ClinicalTrials.gov |
What this trial studies
The RSSearch Registry is an international database that collects data on the use of Stereotactic Radiosurgery (SRS) and Stereotactic Body Radiation Therapy (SBRT) for treating various tumors and conditions. It aims to track treatment practices and outcomes over time, allowing healthcare providers to analyze the effectiveness of these therapies. Participants can record patient characteristics, treatment plans, and outcomes, facilitating quality improvement and collaboration among treatment centers. The registry also includes both prospective enrollment and retrospective data to capture comprehensive treatment outcomes.
Who should consider this trial
Good fit: Ideal candidates include patients diagnosed with benign or malignant tumors or other conditions treatable by SRS/SBRT.
Not a fit: Patients who are unwilling to sign the informed consent document will not benefit from this study.
Why it matters
Potential benefit: If successful, this registry could enhance the understanding and effectiveness of SRS/SBRT treatments, leading to improved patient outcomes.
How similar studies have performed: Other studies utilizing registries for tracking treatment outcomes have shown success, indicating that this approach is both tested and valuable.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Diagnosis of benign or malignant tumors or other conditions deemed treatable by stereotactic radiosurgery or stereotactic body radiotherapy * Willingness to sign an Informed Consent Document or verbally agree to participation Exclusion Criteria: * There are no specific exclusion criteria, but patients who are unwilling to sign the ICD or who decline participation will not be included
Where this trial is running
Colorado Springs, Colorado and 12 other locations
- Penrose Cancer Center — Colorado Springs, Colorado, United States (Enrolling_by_invitation)
- Sylvester Comprehensive Cancer Center, University of Miami — Miami, Florida, United States (Recruiting)
- Southeast Georgia Health System — Brunswick, Georgia, United States (Enrolling_by_invitation)
- Henry Ford Health System — Detroit, Michigan, United States (Recruiting)
- AtlantiCare Regional Medical Center and AtlantiCare Cancer Care Institute — Egg Harbor, New Jersey, United States (Enrolling_by_invitation)
- Riverview Medical Center — Red Bank, New Jersey, United States (Enrolling_by_invitation)
- NJ Cyberknife at Community Medical Center — Toms River, New Jersey, United States (Enrolling_by_invitation)
- Montefiore Medical Center — The Bronx, New York, United States (Enrolling_by_invitation)
- Geisinger Health System — Danville, Pennsylvania, United States (Enrolling_by_invitation)
- Philadelphia CyberKnife — Philadelphia, Pennsylvania, United States (Enrolling_by_invitation)
- Pottstown Memorial Medical Center — Pottstown, Pennsylvania, United States (Enrolling_by_invitation)
- Cyberknife at Erlanger — Chattanooga, Tennessee, United States (Enrolling_by_invitation)
- St. Mary's Medical Center — Huntington, West Virginia, United States (Enrolling_by_invitation)
Study contacts
- Study coordinator: Jan Jenkins, RN
- Email: jjenkins@therss.org
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.